Rhamnazin, a novel inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy
- 1 March 2015
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 458 (4) , 913-919
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81400372, 81160118, 81260113)
- Clinical Medicine Research Special-purpose Foundation of China (L2012052)
- Science and Technology Platform Construction Project of Jiangxi Province (2013-116)
- Jiangxi Province Sailing Engineering (201422)
- Education Department Youth Scientific Research Foundation (GJJ14170)
- Youth Science Foundation of Jiangxi Province (20114BAB215036)
- Science Technology Foundation of Jiangxi Province (20111BBG70026-2)
- Health development planning commission Science Foundation of Jiangxi Province (20155154)
This publication has 21 references indexed in Scilit:
- Association of VEGF-A Splice Variant mRNA Expression With Outcome in Bevacizumab-Treated Patients With Metastatic Breast CancerClinical Breast Cancer, 2014
- Efficacy of biological agents in metastatic triple-negative breast cancerCancer Treatment Reviews, 2014
- Isolation, Identification and Activities of Natural Antioxidants from Callicarpa kwangtungensis ChunPLOS ONE, 2014
- Phosphorylated VEGFR2 and hypertension: potential biomarkers to indicate VEGF-dependency of advanced breast cancer in anti-angiogenic therapyBreast Cancer Research and Treatment, 2013
- Concerted Suppression of STAT3 and GSK3β Is Involved in Growth Inhibition of Non-Small Cell Lung Cancer by XanthatinPLOS ONE, 2013
- Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancerJournal of Clinical Investigation, 2013
- Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressivenessHistopathology, 2012
- Current management and treatment strategies for breast cancerCurrent Opinion in Obstetrics and Gynecology, 2012
- Encapsulation of docetaxel in oily core polyester nanocapsules intended for breast cancer therapyDiscover Nano, 2011
- Acetyl-11-Keto-β-Boswellic Acid Inhibits Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2–Mediated AngiogenesisCancer Research, 2009